Humors Tech's flagship product, Respyr, is a breath-based health screening tool that integrates with wearables and fitness apps to identify and track conditions such as diabetes, hypertension, heart, liver, kidney, and respiratory problems. Respyr also acts as a gateway to telemedicine platforms, connecting users with timely medical interventions based on screening results. The company operates a dual B2B and B2B2C model serving corporates, insurers, government hospitals, remote healthcare facilities, and consumers, and offers applications for insurance participation, employee health programs, quick medical screening, and remote healthcare access. Humors Tech plans to use the funding to expedite the commercial launch of Respyr, conduct clinical validation research, and pursue international market expansion. The company was founded by Ankur Jaiswal and Suchita Kanaldekar. Its initial serviceable available market (SAM) is cited as 163 million health-conscious people, with a total addressable market (TAM) of 612 million in India.

Total raised

$0M

Funding rounds

1

Latest round

Seed

Latest activity

May 2024